Actuate Therapeutics (NASDAQ:ACTU) Now Covered by Analysts at HC Wainwright
HC Wainwright assumed coverage on shares of Actuate Therapeutics (NASDAQ:ACTU – Free Report) in a report issued on Monday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $20.00 price objective on the stock. Actuate Therapeutics Stock Performance Shares of ACTU stock opened at $7.40 on Monday. The business has a 50 […]
HC Wainwright assumed coverage on shares of Actuate Therapeutics (NASDAQ:ACTU – Free Report) in a report issued on Monday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $20.00 price objective on the stock. Actuate Therapeutics Stock Performance Shares of ACTU stock opened at $7.40 on Monday. The business has a 50 […]
